DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $135,356,535 | -27.9% | 615,393 | -21.3% | 0.96% | -29.3% |
Q2 2023 | $187,689,120 | -13.8% | 782,038 | -16.7% | 1.36% | -10.2% |
Q1 2023 | $217,762,873 | -13.1% | 938,690 | -0.6% | 1.51% | -10.7% |
Q4 2022 | $250,641,085 | +9.5% | 944,363 | +6.6% | 1.69% | +4.8% |
Q3 2022 | $228,924,000 | +1.6% | 886,262 | -0.3% | 1.61% | -13.0% |
Q2 2022 | $225,328,000 | -8.6% | 888,842 | +5.8% | 1.86% | +10.6% |
Q1 2022 | $246,401,000 | -17.1% | 840,051 | -7.0% | 1.68% | -11.6% |
Q4 2021 | $297,054,000 | +21.3% | 902,873 | +12.3% | 1.90% | +13.9% |
Q3 2021 | $244,834,000 | +5.9% | 804,246 | -6.6% | 1.66% | +5.2% |
Q2 2021 | $231,097,000 | +36.3% | 861,147 | +8.4% | 1.58% | +12.1% |
Q1 2021 | $169,536,000 | -3.9% | 794,526 | -0.0% | 1.41% | +1.0% |
Q4 2020 | $176,504,000 | +7.4% | 794,530 | +4.1% | 1.40% | -9.5% |
Q3 2020 | $164,277,000 | +56.3% | 762,942 | +28.4% | 1.54% | +39.1% |
Q2 2020 | $105,092,000 | +123.0% | 594,284 | +89.2% | 1.11% | +112.5% |
Q1 2020 | $47,134,000 | -2.2% | 314,164 | +0.0% | 0.52% | +1.0% |
Q4 2019 | $48,208,000 | +153.5% | 314,097 | +138.5% | 0.52% | +105.2% |
Q3 2019 | $19,020,000 | -28.2% | 131,691 | -29.2% | 0.25% | -23.6% |
Q2 2019 | $26,480,000 | +13.9% | 186,098 | +5.7% | 0.33% | +11.1% |
Q1 2019 | $23,242,000 | -46.0% | 176,044 | -57.8% | 0.30% | -55.1% |
Q4 2018 | $43,032,000 | -7.3% | 417,314 | -2.3% | 0.66% | +7.1% |
Q3 2018 | $46,433,000 | +246.9% | 427,319 | +215.1% | 0.62% | +191.0% |
Q2 2018 | $13,384,000 | +143.5% | 135,629 | +141.6% | 0.21% | +125.5% |
Q1 2018 | $5,497,000 | +11.1% | 56,143 | +5.3% | 0.09% | +9.3% |
Q4 2017 | $4,950,000 | -51.6% | 53,334 | -55.3% | 0.09% | -52.0% |
Q3 2017 | $10,227,000 | +100.6% | 119,220 | +97.4% | 0.18% | +86.5% |
Q2 2017 | $5,097,000 | +4.3% | 60,397 | +5.7% | 0.10% | +1.1% |
Q1 2017 | $4,886,000 | +37.2% | 57,118 | +24.9% | 0.10% | +15.9% |
Q4 2016 | $3,560,000 | -42.9% | 45,743 | -42.5% | 0.08% | -45.3% |
Q3 2016 | $6,240,000 | -69.2% | 79,604 | -60.3% | 0.15% | -71.5% |
Q2 2016 | $20,247,000 | -1.0% | 200,461 | -7.5% | 0.53% | +2.9% |
Q1 2016 | $20,444,000 | +42.9% | 216,690 | +40.7% | 0.51% | +33.4% |
Q4 2015 | $14,309,000 | +392.1% | 154,055 | +351.4% | 0.38% | +439.4% |
Q3 2015 | $2,908,000 | -5.7% | 34,129 | -5.3% | 0.07% | +10.9% |
Q2 2015 | $3,083,000 | -73.9% | 36,023 | -74.1% | 0.06% | -73.1% |
Q1 2015 | $11,829,000 | +291.9% | 139,292 | +295.6% | 0.24% | +277.8% |
Q4 2014 | $3,018,000 | – | 35,206 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |